智通财经APP讯,圣诺医药-B(02257)发布公告,于2026年3月24日,董事会议决建议终止2022年受限制股份单位计划及采纳2026年受限制股份单位计划,并由股东于公司将召开的股东特别大会上批准。
智通财经APP讯,圣诺医药-B(02257)发布公告,于2026年3月24日,董事会议决建议终止2022年受限制股份单位计划及采纳2026年受限制股份单位计划,并由股东于公司将召开的股东特别大会上批准。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.